Skip to main content
Caplight Logo









Asclepii

Asclepii

Private
Cleveland, OhioHealthcare & Life Scienceshttps://asclepii.com/

Last Round

Grant

Apr 8, 2025

Total Funding Raised

$2.52M

Company Overview

Asclepii is a biotechnology company that develops regenerative medicine and advanced wound care solutions, including its flagship nanosilver hydrogel product, Poseidon.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

advanced wound careregenerative medicinenanosilver hydrogelextracellular matrixdiabetic foot ulcerswound dressingbiotech startuptissue regenerationmedical devicewound healingbiomaterialsmedtechchronic wound managementFDA-cleared

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Asclepii Comparables

Compare Asclepii with similar companies based on industry and business-model similarity.

Asclepii comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Organogenesis Holdings Inc.
75%
ConvaTec Group PLC
74%
ParaNano Wound Care
74%

Asclepii Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantApr 8, 2025
SeedMar 21, 2025
GrantApr 26, 2024
AcceleratorApr 17, 2024
GrantMar 8, 2024

Key People

Founding team and executive leadership

Franco Kraiselburd

Founder & CEO

Founding Team

Asclepii Investors

Notable investors and investment history

Asclepii investors
InvestorRounds
VenturanceSeed
Zentynel Frontier InvestmentsSeed
JumpStartAccelerator
Capital FactorySeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 22, 2026

    Monthly visitors grew 42% MoM.

  • Jun 1, 2025

    Monthly visitors increased 468% MoM.

Recent news

Latest coverage and updates

  • attends_eventSep 4, 2026

    Asclepii will attend event Vizient Innovative Technology Exchange on Sep 24th '26.

Asclepii Filings

Explore SEC and related filing metadata, where available.

Asclepii filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Asclepii's valuation, stock price, and market status.

Is Asclepii a public or private company?

Asclepii is a private company.

What is the current stock price of Asclepii?

Asclepii is a private company with no public stock price. No recent secondary market data is available.

How much is Asclepii worth (valuation)?

Valuation information for Asclepii is not publicly available.

Can I buy Asclepii stock?

Asclepii shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Asclepii's last funding round?

Asclepii's most recent funding round was Grant on April 8, 2025.

Who are the main investors in Asclepii?

Key investors in Asclepii include Zentynel Frontier Investments.

Will Asclepii IPO soon?

No public IPO plans have been announced for Asclepii.

How can I track Asclepii secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Asclepii's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCleveland, Ohio
Employee Range13
Year Founded2022
Last FundingApr 8, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?